✦ LIBER ✦

613 Pharmacokinetics/pharmacodynamics (PK/PD) of GSK2256098, a Focal Adhesion Kinase (FAK) Inhibitor, in Patients with Advanced Solid Tumors

✍ Scribed by Gan, H.; Nebot, N.; Soria, J.C.; Arkenau, H.T.; Blagden, S.; Plummer, R.; Ranson, M.; Evans, T.R.J.; Zalcman, G.; Peddareddigari, V.; Gibson, D.; Murray, S.; Mazumdar, J.; Fleming, R.; Auger, K.; Millward, M.

Book ID: 122715916
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 60 KB
Volume: 48
Category: Article
ISSN: 0959-8049
DOI: 10.1016/S0959-8049(12)72410-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1455 POSTER Safety, pharmacokinetics (PK

1455 POSTER Safety, pharmacokinetics (PK), and pharmacodynamics (PD) of AMG 706 in patients (pts) with advanced solid tumors

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 142 KB

610 Loss of the Tumor Suppressor Merlin

610 Loss of the Tumor Suppressor Merlin as a Potential Predictive Biomarker of Clinical Activity for the Oral, Focal Adhesion Kinase (FAK) Inhibitor GSK2256098 in Pts with Recurrent Mesothelioma

✍ Soria, J.C.; Plummer, R.; Ranson, M.; Gan, H.; Arkenau, H.T.; Zalcman, G.; Blagd 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 58 KB

404 POSTER Pharmacodynamics (pd) of x188

404 POSTER Pharmacodynamics (pd) of x1880, a novel spectrum selective kinase inhibitor (SSKI), administered orally to patients (pts) with advanced solid tumors (AST)

✍ P. LoRusso; L. Appleman; A. Zhu; G. Shapiro; L. Fox; A. Wolanski; S. Hitchcock-B 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 60 KB

75 POSTER Pharmacokinetic (PK)-pharmacod

75 POSTER Pharmacokinetic (PK)-pharmacodynamic correlation, biologic and clinical effects of GW786034 (pazopanib), a VEGF tyrosine kinase inhibitor (TKI), in patients (pts) with solid tumors

✍ B. Suttle; S. Saini; S. Kathman; T. Arumugham; B. Whitehead; A. Nixon; H. Hurwit 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 58 KB

600 Pharmacokinetics and Pharmacodynamic

600 Pharmacokinetics and Pharmacodynamics of a Selective Oral MEK1/2 Inhibitor, Pimasertib (MSC1936369B/AS703026), in Patients with Advanced Solid Tumors

✍ Houédé, N.; Delord, J.P.; Awada, A.; Lebbe, C.; Lesimple, T.; Schellens, J.H.M.; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Population pharmacokinetics of a HER2 ty

Population pharmacokinetics of a HER2 tyrosine kinase inhibitor CP-724,714 in patients with advanced malignant HER2 positive solid tumors

✍ Feng Guo; Stephen P. Letrent; Amarnath Sharma 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 281 KB